[1] 吴奇光.口腔组织病理学[M].第3版.北京:人民卫生出版社,1994.18
[2] Kong X, Wang Y,Dai C, et al. Is CD147 a new biomarker reflecting histological malignancy of gliomas? [J]. Mol Neurobiol, 2017,54(2)∶1568-1576
[3] Saentaweesuk W, Araki N,Vaeteewoottacharn K, et al. Activation of vimentin is critical to promote a metastatic potential of cholangiocarcinoma cells [J]. Oncol Res, 2017, 26(4)∶605-616
[4] 金伯泉.白细胞分化抗原[M].见:金伯泉主编.细胞和分子免疫学.第2版.北京:科学出版社, 2001.4-7
[5] Norgauer J, Hildenbrand T, Idzko M, et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers [J]. Br J Dermatol,2015,147(6)∶1180-1186
[6] 林才照. 一种新型抗VEGF靶向制剂的抗肿瘤血管生成作用机制研究[D].浙江大学, 2012
[7] 徐小艳,徐宪伟,王慧,等. 肺腺癌中 CD147、MMP-9和VEGF的表达及临床意义[J].临床与实验病理学杂志,2017,33(4)∶384-387
[8] 耿杰杰.CD147对T细胞谱系的维持作用及作为肿瘤免疫治疗靶点的机制研究[D].第四军医大学, 2016
[9] 王苏春,王禾,秦卫军,等.CD147、MMP-9 与 VEGF在肾细胞癌中的表达及其临床意义[J].蚌埠医学院学报,2011,36(11)∶1194-1197
[10] 檀紫瑞.CXCR4和MMP-9在非小细胞肺癌中的表达及意义[D].河北医科大学, 2013
[11] 邹海啸, 杨海丽, 赵怡芳,等.普萘洛尔对人黑色素瘤A375细胞增殖迁移和血管生成能力的影响及其机制研究[J].口腔医学研究,2018,34(2)∶139-143
[12] Gou X, He WY, Xiao MZ, et al. Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats [J]. Asian J Androl, 2011, 13(2)∶332-338
[13] 殷悦.CD147和MMP-9的表达与涎腺肿瘤侵袭性的关系[D].吉林大学,2011
[14] 顾鑫,易为民,彭创.CD147与恶性肿瘤治疗关系的研究进展[J].医学综述,2015(3)∶399-400
[15] Annah zi A, brah m S, Farkas K, et al. A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer [J]. Br J Cancer, 2016, 114(7)∶787-792
[16] 马静, 余州,李明阳,等.转移性肾细胞癌中RSK4、CD44及MMP-9的表达及意义[J].临床与实验病理学杂志,2017,33(8)∶852-857
[17] Jia L, Wang H, Qu S, et al. CD147 regulates vascular endothelial growth factor-A expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma [J]. IUBMB Life, 2010, 60(1)∶57-63 |